PR-39 is an endogenous proline-rich antimicrobial peptide which induces the synthesis of syndecan-1, a transmembrane heparan sulphate proteoglycan involved in cell-to-matrix interactions and wound healing. Previously, we revealed that the expression of syndecan-1 was reduced in human hepatocellular carcinomas with high metastatic potential and speculated that syndecan-1 played an important role in inhibition of invasion and metastasis. It is assumed that a modification of this process with PR-39 and syndecan-1 may result in a new strategy by which it can inhibit the invasion and metastasis. Therefore, we transduced a gene of PR-39 into human hepatocellular carcinoma cell line HLF, which shows a low expression of syndecan-1 and a high in vitro invasive activity, and examined whether this procedure could reduce the invasive activity of tumour cells. In two transfectants with PR-39 gene, the syndecan-1 expression was induced and the invasive activity in type I collagen-coated chamber was inhibited. Moreover, these transfectants showed the suppression of motile activity assayed by phagokinetic tracks in addition to the disorganization of actin filaments observed by a confocal imaging system. In contrast, five transfectants with syndecan-1 gene in the HLF cells revealed suppression of invasive activity but did not alter the motile activity and actin structures of the cell. These results suggest that PR-39 has functions involved in the suppression of motile activity and alteration of actin structure on human hepatocellular carcinoma cells in addition to the suppression of invasive activity which might result from the induction of syndecan-1 expression.
Agerberth, B, Lee, J-Y, Bergman, T, Carlquist, M, Boman, HG, Mutt, V & Jornvall, H (1991). Amino acid sequence of PR-39: isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem 202: 849–854.
Agerberth, B, Gunne, H, Odeberg, J, Kogner, P, Boman, HG & Gudmundsson, GH (1995). FALL-39, putative human peptide antibiotics, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 92: 195–199.
Agerberth, B, Gunne, H, Odeberg, J, Kogner, P, Boman, HG & Gudmundsson, GH (1996). PR-39, a proline-rich peptide antibiotic from pig, and FALL-39, a tentative human counterpart. Vet Immunol Immunopathol 54: 127–131.
Albini, A, Iwamoto, Y, Kleinmann, HK, Martin, GR, Aaronson, SA, Kozolowski, JM & Ecewan, RN (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239–3245.
Albrecht-Buehler, G (1977). The phagokinetic tracks of 3T3 cells. Cell 11: 359–404.
Aycock, RS & Seyer, JM (1989). Collagens of normal and cirrhotic human liver. Connect Tissue Res 23: 19–31.
Bernfield, M, Hinkes, MT & Gallo, RL (1993). Developmental expression of the syndecans: possible function and regulation. Development Suppl: 205–212.
Boman, HG, Agerberth, B & Boman, A (1993). Mechanism of action on Escherichia coli of Cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 61: 2978–2984.
Boman, HG (1995). Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13: 61–92.
Chan, YR & Gallo, RL (1998). PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130Cas. J Biol Chem 273: 28978–28985.
Dickson, RB, Johnson, MD, Maemura, M & Low, J (1996). Anti-invasion drugs. Breast Cancer Res Treat 38: 121–132.
Doi, I, Namba, M & Sato, L (1975). Establishment and some biological characteristics of human hepatoma cell lines. Jpn J Cancer Res 66: 385–392.
Effert, PJ, Gastl, G & Strohmeyer, T (1996). Current and future strategies to block tumor angiogenesis, invasion, and metastasis. World J Urol 14: 131–140.
Elenius, K, Salmivirta, M, Inki, P, Mali, M & Jalkanen, M (1990). Binding of human syndecan to extracellular matrix proteins. J Biol Chem 265: 17837–17843.
Elenius, K, Määttä, A, Salmivirta, M & Jalkanen, M (1992). Growth factors induce 3T3 cells to express bFGF-binding syndecan. J Biol Chem 267: 6435–6441.
Gallo, RL, Ono, M, Povsic, T, Page, C, Eriksson, E, Klagsbrunl, M & Bernfield, M (1994). Syndecan, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci USA 91: 11035–11039.
Gout, I, Dhand, R, Hiles, ID, Fry, MJ, Panayotou, G, Das, P, Truong, O, Totty, NF, Hsuan, J, Booker, GW, Campbell, ID & Waterfield, MD (1993). The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell 75: 25–36.
Hinkes, MT, Goldberger, OA, Neumann, PE, Kokenyesi, R & Bernfield, M (1993). Organization and promoter activity of the mouse syndecan-1 gene. J Biol Chem 268: 11440–11448.
Huh, N & Utakoji, T (1981). Production of HBs-antigen by two new human hepatoma cell lines and its enhancement by dexamethasone. Jpn J Cancer Res 72: 178–179.
Koda, JE, Rapraeger, A & Bernfield, M (1985). Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycans as a receptor for interstitial collagens. J Biol Chem 260: 8157–8162.
Liebersbach, BF & Sanderson, RD (1994). Expression of syndecan-1 inhibit cell invasion into type I collagen. J Biol Chem 269: 20013–20019.
Martin, E, Ganz, T & Lehrer, RI (1995). Defensins and other endogenous peptide antibiotics of vertebrates. J Leukocyte Biol 58: 128–136.
Matsumoto, A, Ono, M, Fujimoto, Y, Gallo, RL, Bernfield, M & Kohgo, Y (1997). Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. Int J Cancer 74: 482–491.
Musacchio, A, Wilmanns, M & Saraste, M (1994). Structure and function of the SH3 domain. Prog Biophys Molec Biol 61: 283–297.
Pawson, T (1995). Protein modules and signaling networks. Nature 373: 573–580.
Rapraeger, A, Jalkanen, M, Endo, E, Koda, JE & Bernfield, M (1985). The cell-surface proteoglycan from mouse mammary epithelial cells bears chondroitin-sulfate and heparan-sulfate GAGs. J Biol Chem 260: 11046–11052.
Sanderson, RD & Bernfield, M (1988). Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia. Proc Natl Acad Sci USA 85: 9562–9566.
Sanderson, RD, Hinkes, MT & Bernfield, M (1992). Syndecan-1, a cell-surface proteoglycan, changes in size and abundance when keratinocytes stratify. J Invest Dermatol 99: 390–396.
Saunders, S & Bernfield, M (1988). Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor on interstitial matrix. J Cell Biol 106: 423–430.
Saunders, S, Jalkanen, M, O’Farrell, S & Bernfield, M (1989). Molecular cloning of syndecan, an integral membrane proteoglycan. J Cell Biol 108: 1547–1556.
Shi, J, Ross, CR, Leto, TL & Blecha, F (1996). PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47phox. Proc Natl Acad Sci USA 93: 6014–6018.
Solursh, M, Reiter, RS, Jensen, KL, Kato, M & Bernfield, M (1990). Transient expression of a cell surface heparan sulfate proteoglycan (syndecan) during limb development. Dev Biol 140: 83–92.
Storici, P & Zanetti, M (1993). A cDNA derived from pig bone marrow cells predicts a sequence identical to the intestinal antibacterial peptide PR-39. Biochem Biophys Res Commun 196: 1058–1065.
Stossel, T (1993). On the crawling of animal cells. Science 260: 1086–1094.
Vanio, S, Lehtonen, E, Jalkanen, M, Bernfield, M & Saxen, L (1989). Epithelial– mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney. Dev Biol 134: 382–391.
Vainio, S & Thesleff, I (1992). Coordinated induction of cell proliferation and syndecan expression in dental mesenchyme by epithelium: evidence for diffusible signals. Dev Dyn 194: 105–117.
Yeaman, C & Rapraeger, A (1993). Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages. J Cell Biol 122: 941–950.
Yu, H, Chen, JK, Feng, S, Dalgarno, DC, Brauer, AW & Schreiber, SL (1994). Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76: 933–945.
Correspondence to: Y Fujimoto
About this article
Cite this article
Ohtake, T., Fujimoto, Y., Ikuta, K. et al. Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells. Br J Cancer 81, 393–403 (1999). https://doi.org/10.1038/sj.bjc.6690707
- antimicrobial peptide
- hepatocellular carcinoma
Journal of Inflammation (2006)